COVID-19 and metabolic diseases: a heightened awareness of health inequities and a renewed focus for research priorities
- 8 February 2021
- journal article
- review article
- Published by Elsevier BV in Cell Metabolism
- Vol. 33 (3), 473-478
- https://doi.org/10.1016/j.cmet.2021.02.006
Abstract
No abstract availableKeywords
Funding Information
- National Institute of Diabetes and Digestive and Kidney Diseases
This publication has 28 references indexed in Scilit:
- The obesity transition: stages of the global epidemicThe Lancet Diabetes & Endocrinology, 2019
- Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017The Lancet, 2018
- Economic Costs of Diabetes in the US in 2017Diabetes Care, 2018
- The Science of Obesity Management: An Endocrine Society Scientific StatementEndocrine Reviews, 2018
- Association of Modifiable Risk Factors in Young Adulthood With Racial Disparity in Incident Type 2 Diabetes During Middle AdulthoodJama-Journal Of The American Medical Association, 2017
- Social Determinants of Health and Racial/Ethnic Disparities in Type 2 Diabetes in YouthCurrent Diabetes Reports, 2017
- Youth-Onset Type 2 Diabetes Consensus Report: Current Status, Challenges, and PrioritiesDiabetes Care, 2016
- Prevalence of and Trends in Diabetes Among Adults in the United States, 1988-2012Jama-Journal Of The American Medical Association, 2015
- Changes in Diabetes-Related Complications in the United States, 1990–2010The New England Journal of Medicine, 2014
- Estimated morbidity and mortality in adolescents and young adults diagnosed with Type 2 diabetes mellitusDiabetic Medicine, 2012